TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REKEMEND

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

REKEMEND

ST13

US500000090596028

Class

5

Filing

90596028

Registration

7803706

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

05/20/2025

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

03/23/2021

Registration date

05/20/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/20/2025

Last transaction

05/20/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2021-00-00

First use in commerce

2021-00-00

Drawing code

4

Owner type

16

Owner location

HOLLYWOOD, FL

Examiner

PRATER, JILL

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

REKEMEND LLC
1295286 B.C. LTD.

Representatives

Anuj Desai ARNALL GOLDEN GREGORY LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Appetite suppressant pills; Appetite suppressants; Appetite suppressants for medical purposes; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Fungal medications; Nutraceuticals for use as a dietary supplement; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical skin lotions; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Balms for pharmaceutical purposes; Dietary supplement beverage for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary supplement drink mixes; Dietary supplements; Dietary supplements also containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Dietary supplements for controlling cholesterol; Dietary supplements for human consumption; Dietary and nutritional supplements; Dietary and nutritional supplements containing adaptogens, nootropics, mushrooms and mushroom extracts; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements for supporting immunity, enhancing mood and well-being, and suppressing appetite; Dietary and nutritional supplements used for weight loss; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplements in the nature of weight loss powders; Dietetic preparations adapted for medical purposes; Flour for pharmaceutical purposes; Food supplements; Health food supplements; Homeopathic supplements; Liquid nutritional supplement; Natural supplements for treating depression and anxiety; Natural dietary supplements; Nutraceuticals for use as a dietary supplement for supporting immunity, enhancing mood and well-being, and suppressing appetite; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of adaptogens, nootropics, mushrooms and mushroom extracts; Pharmaceutical preparations, namely, appetite suppressants; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Therapeutic agents for weight control and appetite suppression; Weight management supplements

Publications

History of USPTO decisions and trademark events.

37 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/20/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/20/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

04/25/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

04/25/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

04/14/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

04/14/2025

IUAF

USE AMENDMENT FILED

02/03/2025

EISU

TEAS STATEMENT OF USE RECEIVED

02/03/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/01/2024

EX5G

SOU EXTENSION 5 GRANTED

08/01/2024

EXT5

SOU EXTENSION 5 FILED

08/01/2024

EEXT

SOU TEAS EXTENSION RECEIVED

08/01/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/03/2024

EX4G

SOU EXTENSION 4 GRANTED

02/01/2024

EXT4

SOU EXTENSION 4 FILED

02/01/2024

EEXT

SOU TEAS EXTENSION RECEIVED

02/01/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/03/2023

EX3G

SOU EXTENSION 3 GRANTED

08/01/2023

EXT3

SOU EXTENSION 3 FILED

08/01/2023

EEXT

SOU TEAS EXTENSION RECEIVED

08/01/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/03/2023

EX2G

SOU EXTENSION 2 GRANTED

02/01/2023

EXT2

SOU EXTENSION 2 FILED

02/01/2023

EEXT

SOU TEAS EXTENSION RECEIVED

02/01/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/03/2022

EX1G

SOU EXTENSION 1 GRANTED

08/01/2022

EXT1

SOU EXTENSION 1 FILED

08/01/2022

EEXT

SOU TEAS EXTENSION RECEIVED

08/01/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/01/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/12/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/07/2021

PUBO

PUBLISHED FOR OPPOSITION

12/07/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/17/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/29/2021

DOCK

ASSIGNED TO EXAMINER

10/28/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/26/2021

NWAP

NEW APPLICATION ENTERED

03/26/2021

Continuous trademark protection

Get notified about every new filing that threatens REKEMEND or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.